Company Profile
MPA Technical Devices Srl is an Italian company specializing in designing and manufacturing top quality and accurate dosing systems.
We achieve the highest standards of precision for dosing all kinds of pharmaceutical substances thanks to over 20 years of experience, a technologically advanced workshop and constant innovation in design. We aim for tailored solutions designed to meet our customers needs and requirements.
Engineering & Design
A highly skilled team of designers can develop customized projects starting from the specifications of the pharmaceutical machine or from the characteristics of the liquids to be dosed. We ensure customer-focused advice, we analyse each problem and propose customized solutions to optimise the performance of the entire production line. It is also possible to re-design or to improve parts or existing systems, to achieve the best results based on users’ feedbacks. The final products are complete with surface treatments as well as special coatings. Components are laser marked on customer request. MPA Technical Devices offers a comprehensive service, support and technical advice from design to final installation.
Company Philosophy
Our goal is to ensure long service life and perfection in every one of our products.
We aim for the highest levels of dosing accuracy and precision since we strongly believe that details lead to perfection in terms of quality and reliability.
“Details make perfection, and perfection is not a detail.” – Leonardo da Vinci
Quality & Traceability
MPA Technical Devices has always used Food&Pharma regulations compliant material coming from European steelworks and manufacturers MOCA or FDA certified, ensuring maximum quality of products thanks to strict controls on raw materials.
On delivery, we check and cross reference each raw material bar to the corresponding certificate number. When the material is cut, the certificate number is linked to the workpiece, achieving in this way a real traceability for each component of our products.
The final product must meet the highest quality standards monitored with appropriate measuring equipment. Products certifications include the tests reports carried out.
Scanning an optional QR code on the product, our customers can have immediate access from their tablet or smartphone to the 3.1 certificates, special coatings, treatments, quality and roughness reports.
We consider quality and transparency of primary importance: for this reason, we regularly test the materials and coatings of our products in independent and ISO certified laboratories, making the reports available to our customers.
Related News
-
News Women in Pharma: Moving beyond discussions and into best practice at CPHI Milan
In this second CPHI Milan special of our monthly series, we cover the key takeaways from the Diversity & Wellbeing track held on October 10, 2024. -
News AstraZeneca invests in AI collaboration for cancer drug trials
The British-Swedish pharmaceutical giant is partnering with biotechnology firm Immunai Inc to increase the efficiency of some cancer drug trials. -
News Ozempic and Wegovy prices questioned as Novo Nordisk faces US Senate hearing
The CEO of Novo Nordisk was grilled during a US Senate committee hearing on September 24, 2024, in which the exorbitant prices of the Danish company’s blockbuster drugs Ozempic and Wegovy were called into question. -
News The BIOSECURE Act: implications for the pharma supply chain
On September 9, 2024, the US House of Representatives voted to pass the bill titled the BIOSECURE Act (the Act), which lists several Chinese companies in the pharmaceutical supply chain. The Act will prohibit American companies from contracting or doin... -
News On Track at CPHI Milan: Thermo Fisher Scientific Track Sponsor interview
With CPHI Milan just around the corner, we sat down with some of the sponsors for this year’s conference tracks to discuss the most pressing topics in pharma. -
News CPHI Milan Speaker Spotlight: Pharma Manufacturing and Localisation in Africa
In the run-up to CPHI Milan, we sit down with some of the experts and thought-leaders speaking at this year’s conferences. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Eli Lilly licenses rheumatoid arthritis manufacturing in Africa
American pharmaceutical company Eli Lilly has signed a partnership with Egyptian organisation Eva Pharma to localise manufacturing of rheumatoid arthritis treatments in Africa.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance